Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Jun;51(2):253-7.
doi: 10.1111/j.1476-5381.1974.tb09655.x.

Dissociation of cardiac inotropic and adenylate cyclast activating adrenoceptors

Dissociation of cardiac inotropic and adenylate cyclast activating adrenoceptors

B G Benfey et al. Br J Pharmacol. 1974 Jun.

Abstract

1 At higher temperatures, near the physiological range for mammals and nonhibernating frogs, the adrenoceptors for both inotropic responses to adrenaline and noradrenaline and for cyclic 3',5'-adenosine monophosphate (cyclic AMP) production in rat and frog isolated heart preparations, had typical beta characteristics. Phenoxybenzamine potentiated the inotropic response and the accumulation of cyclic AMP; conversely, propranolol inhibited the two responses.2 When the ambient temperature was reduced, the adrenoceptors mediating cyclic AMP production changed very little; they were blocked as effectively as at the higher temperature by propranolol and were not blocked by phenoxybenzamine. However, the adrenoceptors mediating the inotropic response were markedly changed by the decrease in temperature; phenoxybenzamine now inhibited this response and the inhibitory activity of propranolol was reduced about tenfold.3 These results indicate that the adrenoceptors that mediate cardiac inotropic responses at physiological temperatures are distinct from those that mediate the production of cyclic AMP, and that the activation of adenylate cyclase and the accumulation of cyclic AMP are probably not intermediate steps in cardiac inotropic responses to catecholamines.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Int Pharmacodyn Ther. 1966 Apr;160(2):379-89 - PubMed
    1. Br J Pharmacol Chemother. 1967 Aug;30(3):603-11 - PubMed
    1. Nature. 1968 Mar 16;217(5133):1077-8 - PubMed
    1. J Pharmacol Exp Ther. 1968 Jan;159(1):82-90 - PubMed
    1. J Pharmacol Exp Ther. 1968 Oct;163(2):379-85 - PubMed

MeSH terms

LinkOut - more resources